Yoga has become a popular approach to improve emotional health. The aim of this review was to systematically assess and meta-analyze the effectiveness and safety of yoga for anxiety. Medline/PubMed, Scopus, the Cochrane Library, PsycINFO, and IndMED were searched through October 2016 for randomized controlled trials (RCTs) of yoga for individuals with anxiety disorders or elevated levels of anxiety. The primary outcomes were anxiety and remission rates, and secondary outcomes were depression, quality of life, and safety. Risk of bias was assessed using the Cochrane tool. Eight RCTs with 319 participants (mean age: 30.0-38.5 years) were included. Risk of selection bias was unclear for most RCTs. Meta-analyses revealed evidence for small short-term effects reported safety-related data but these indicated that yoga was not associated with increased injuries. In conclusion, yoga might be an effective and safe intervention for individuals with elevated levels of anxiety. There was inconclusive evidence for effects of yoga in anxiety disorders.
INTRODUCTION
Anxiety is a normal response to specific situations or events. However, excessive fear or anxiety may be indicative of an anxiety disorder (American Psychiatric Association, 2013) . In generalized anxiety disorder (GAD), elevated levels of anxiety, which are associated with concerns about health, relationships, work, and financial issues, lead to a wide variety of physical symptoms and behavioral changes. Excessive anxiety also has implications for long-term health, with somatic symptoms of anxiety, such as palpitations and irregular heartbeat, associated with an increased risk of cardiovascular disease in women (Nabi et al., 2010) . Anxiety disorders are estimated to range in prevalence from 0.9 to 28.3% worldwide (Baxter, Scott, Vos, & Whiteford, 2013) , with factors contributing to this variation including demographic factors of gender, age, financial status, and culture, as well as methodological differences such as definitions of anxiety disorders and measurement or diagnostic tools. In the United States, 12-month and lifetime prevalence of GAD have been reported as 2.1 and 4.1%, respectively (Grant et al., 2005) .
Psychological approaches and medication are the mainstays of treatment for anxiety disorders (Katzman et al., 2014) . Guidance on the management of GADs and panic attacks recommends lowintensity psychological interventions including psychological therapy (such as cognitive behavioral therapy), medication, and selfhelp (including support groups and exercise) (National Institute for Health and Care Excellence, 2011) . However, many people who experience high levels of anxiety do not seek a medical opinion, or choose not to accept psychological or pharmaceutical interventions, preferring instead to self-manage their condition (Morgan & Jorm, 2009 ).
Yoga, a form of mind-body therapy (National Center for Complementary and Integrative Health, 2015) , has become a popular approach to achieve and maintain "wellness," and is perceived to improve emotional health (Stussman, Black, Barnes, Clarke, & Nahin, 2015) . Practice of yoga is increasing, with lifetime and 12-month prevalence of yoga practice in the United States being 13.2 and 8.9%, respectively (Cramer et al., 2016) . The term "yoga" in the Western context is used to describe practices including physical postures (asanas), breath regulation techniques (pranayama), meditation/mindfulness, and relaxation (De Michelis, 2005) . Yoga classes may also incorporate discussion of yoga philosophy and lifestyle advice. Yoga classes are increasingly available within the community. A variety of different yoga styles or "schools" have emerged that put varying focus on physical and mental practices; ranging from pure meditation or breathing practices to quite intense physical activity (De Michelis, 2005; Feuerstein, 1998) . Additionally, many people follow their own personal home practice. Results of a 2012 US survey indicated 48.8% of US adults who practiced yoga did not attend formal classes; the remaining individuals attended a mean of 1 class per month (Cramer et al., 2016) . Yoga practitioners have reported reduced stress levels and greater relaxation (Stussman et al., 2015) , and treating anxiety is one of the main reasons people give for practicing mind-body therapies such as yoga (Barnes, Bloom, & Nahin, 2008) . Low levels of mindfulness have been found in individuals with GAD and other emotional disorders (Curtiss & Klemanski, 2014) , suggesting potential for approaches that increase mindfulness (Vollestad, Nielsen, & Nielsen, 2012) . Consequently, there has been research interest in assessing the effects of yoga on anxiety.
Previous reviews of the research have been inconclusive. While some reviews now are outdated (Kirkwood, Rampes, Tuffrey, Richardson, & Pilkington, 2005) , others have included participants without anxiety and are thus difficult to interpret (Hofmann, Andreoli, Carpenter, & Curtiss, 2016) .
The prevalence and burden of anxiety disorders, together with the reported beneficial effects of yoga practice, and increased publication of clinical trials indicate that an updated systematic review is required.
The aim of this review was to systematically assess and meta-analyze the effectiveness and safety of yoga in patients with anxiety disorders or related disorders and individuals with elevated levels of anxiety.
MATERIALS AND METHODS
This review was planned and conducted in accordance with PRISMA guidelines (Moher, Liberati, Tetzlaff, & Altman, 2009 ) and the recommendations of the Cochrane Collaboration (Higgins & Green, 2008) .
Eligibility criteria

Types of studies
Randomized controlled trials (RCTs), cluster-randomized trials, and randomized crossover from all countries published in any language were eligible. Study quality or risk of bias in the respective study was not a criterion for inclusion.
Types of participants
To be eligible for the review, studies were required to include the following type of participants:
1. Adults with a diagnosis of an anxiety disorder in accordance with the Diagnostic and Statistical Manual, Third Edition (DSM-III or DSM-III-R), Fourth Edition (DSM-IV or DSM-IV-TR) or Fifth Edition (DSM-V) or the International Classification of Disease 10 (ICD-10).
It was post hoc decided to exclude studies on adults with a diagnosis of obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), or acute stress disorder because these conditions are are no longer classified as anxiety disorders in DSM-V. Studies involving participants with comorbid physical or mental disorders were eligible as long as the comorbidity was not the focus of the study, e.g. studies including some patients with anxiety disorders who also had OCD were eligible while studies including only patients with OCD were excluded.
2.
Adults with a diagnosis of an anxiety disorder as defined above diagnosed based on any other criteria.
3.
Otherwise healthy adults with elevated levels of anxiety at the start of the RCT measured by a validated clinician-based or self-report anxiety symptom questionnaire but without a formal diagnosis of an anxiety disorder.
Differences between the three types of participants were investigated in a subgroup analysis. 
Types of interventions
Cointerventions
Studies allowing individual cointerventions (such as pharmacotherapy)
were eligible if all participants in all groups received the same cointerventions.
Control
Studies comparing yoga to no treatment, usual care, or any active control intervention were eligible. Separate meta-analyses were conducted for different control conditions.
Types of outcome measures
For inclusion in this review, RCTs had to assess at least one of the following primary anxiety outcomes:
1. improvement in the severity of anxiety, measured by validated selfrating or clinician-rated scales, 2. improvement in anxiety measured as the number of patients who reached remission, as measured using validated self-rating or clinician-rated scales.
Secondary outcomes included:
1. improvement in depressive symptoms, measured using validated self-rating scales or clinician-rated scales, 
Search methods
The following electronic databases were searched from their inception through October 13, 2016: Medline (through PubMed), Scopus, the Cochrane Library, PsycINFO, and IndMED. The literature search was constructed around search terms for "yoga" and search terms for "anxiety." For PubMed, the following search strategy was used:
("Anxiety" [MeSH] 
Risk of bias in individual studies
Two pairs of review authors (RL, LW or HC, DA) independently assessed risk of bias on the following domains: selection bias (random sequence generation, allocation concealment), performance bias (blinding of participants and personnel), detection bias (blinding of outcome assessment), attrition bias (incomplete outcome data), reporting bias (selective reporting), and other bias using the Cochrane risk of bias tool (Higgins & Green, 2008) . All domains were scored as (1) low risk of bias, (2) unclear, or (3) high risk of bias (Higgins & Green, 2008) . Discrepancies were discussed with a third review author (HC or RL) until consensus was reached.
Data analysis
Effects of yoga compared to different control interventions were analyzed separately, as were short-, medium-, and long-term effects. Shortterm outcomes were defined as outcome measures taken closest to 12 weeks after randomization, medium-term outcomes as closest to 6 months after randomization, and long-term outcomes as closest to 12 months after randomization.
Assessment of overall effect size
Meta-analyses were conducted using Review Manager 5 software (Version 5.3, The Nordic Cochrane Centre, Copenhagen, Denmark) by a random-effects model if at least two studies assessing this specific outcome were available. For continuous outcomes, standardized mean differences (SMD) with 95% confidence intervals (CI) were calculated as the difference in means between groups divided by the pooled standard deviation (Higgins & Green, 2008) . Where no standard deviations were available, they were calculated from standard errors, CI, or tvalues, or attempts were made to obtain the missing data from the trial authors by email. A negative SMD was defined to indicate beneficial effects of yoga compared to the control intervention for all outcomes (e.g., decreased anxiety) except for health-related quality of life where a positive SMD was defined to indicate beneficial effects (e.g., increased well-being). If necessary, scores were inverted by subtracting the mean from the maximum score of the instrument (Higgins & Green, 2008 ). Cohen's categories were used to evaluate the magnitude of the overall effect size with SMD: 0.2-0.5 categorized as small; 0.5-0.8 as medium, and > 0.8 as large-effect sizes (Cohen, 1998) .
For dichotomous outcomes, odds ratios with 95% CI were calculated by dividing the odds of an adverse event in the intervention group (i.e., the number of participants with the respective type of adverse event divided by the number of participants without the respective type of adverse event) by the odds of an adverse event in the control group (Higgins & Green, 2008) . Where studies reported zero events in one or both intervention groups, a value of 0.5 was added to all cells of the respective study.
Assessment of heterogeneity
Statistical heterogeneity between studies was analyzed using the I 2 statistic, a measure of how much variance between studies can be attributed to differences between studies rather than chance. The magnitude of heterogeneity was categorized as I 2 = 0-24%, low heterogeneity; I 2 = 25-49%, moderate heterogeneity; I 2 = 50-74%, substantial heterogeneity; and I 2 = 75-100%, considerable heterogeneity (Higgins & Green, 2008) . The 2 test was used to assess whether differences in results were compatible with chance alone. Given the low power of this test when only few studies or studies with low sample size were included in a meta-analysis, a P-value ≤ .10 was considered to indicate significant heterogeneity (Higgins & Green, 2008) .
Subgroup and sensitivity analyses
Four subgroup analyses were conducted: 4. Gender (mixed; female only; male only).
To test the robustness of significant results, sensitivity analyses were conducted for studies with low risk of bias on the following domains: selection bias (random sequence generation and allocation concealment), detection bias (blinding of outcome assessment), and attrition bias (incomplete outcome data). If statistical heterogeneity was present in the respective meta-analysis, subgroup and sensitivity analyses were also used to explore possible reasons for heterogeneity.
Risk of bias across studies
If at least 10 studies were included in a meta-analysis, assessment of risk of publication bias was originally planned using funnel plots generated by the Cochrane Review Manager 5 software (Higgins & Green, 2008) . As less than 10 studies were included in each analysis, this was not possible.
RESULTS
Literature search
The results of the literature search and screening process are summarized in Figure 1 . The literature search returned 1,993 records. Of 1,188 nonduplicate records, 1,161 were excluded because they were not randomized, did not include patients with anxiety, did not include relevant outcomes, and/or did not include yoga interventions. Twentyseven full-text articles were assessed, and five were excluded because they were not randomized (Clark et al., 2014; Sharma, Azmi, & Settiwar, 1991; Telles, Gaur, & Balkrishna, 2009; Tolbaños Roche, Miró Barrachina, & Ibáñez Fernández, 2016; Valentine, Meyer-Dinkgräfe, Acs, & Wasley, 2006) . For two further articles, it was unclear whether they were randomized or not (Kozasa et al., 2008; ; the authors of one article clarified that the trial was not randomized (Kozasa et al., 2008) ; both articles were excluded. Eleven further articles were excluded because they did not include relevant participants (i.e., those participants that were defined in our inclusion criteria) (Javnbakht, Hejazi Kenari, & Ghasemi, 2009; Khalsa, Shorter, Cope, Wyshak, & Sklar, 2009; Nemati & Habibi, 2012; Shankarapillai, Nair, & George, 2012; Sureka et al., 2014) or did not assess one of the prespecified primary outcomes (severity of anxiety or remission rates) (Carter et al., 2013; Quinones, Maquet, Velez, & Lopez, 2015; Reddy, Dick, Gerber, & Mitchell, 2014; Rhodes, Spinazzola, & Van Der Kolk, 2016; Shannahoff-Khalsa et al., 1999; van der Kolk et al., 2014) ; one further article was published as a conference abstract only and did not provide enough information to be eligible (Annapoorna, Latha, Bhat, & Bhandary, 2011) . For two articles, it was unclear whether all participants actually had elevated levels of anxiety; the authors of one study clarified that this was the case (Davis, Goodman, Leiferman, Taylor, & Dimidjian, 2015) , those of the other article provided a subgroup analysis for participants with elevated levels of anxiety (de Manincor et al., 2016) . Both articles were thus included. Eight articles were included in the qualitative synthesis (Broota & Sanghvi, 1994; Davis et al., 2015; de Manincor et al., 2016; Gupta & Mamidi, 2013; Norton & Johnson, 1983; Parthasarathy, Jaiganesh, & Duraisamy, 2014; Sahasi, Chawla, Dhar, & Katiyar, 1991; . Two articles did not provide the necessary raw data for meta-analysis (Broota & Sanghvi, 1994; Norton & Johnson, 1983) ; as these data could not be otained from the study authors, both articles were excluded from the meta-analysis (Figure 1 ).
Study characteristics
Characteristics of the sample, interventions, outcome assessment, and results are shown in Table 1 . Of the eight included RCTs, one originated from the United States (Davis et al., 2015) , one from Canada (Norton & Johnson, 1983) , five from India (Broota & Sanghvi, 1994 RCTs included patients with a diagnosis of anxiety disorder of any kind (Parthasarathy et al., 2014) , GAD (Gupta & Mamidi, 2013) , snake phobia (Norton & Johnson, 1983) , or obsolete diagnoses, such as anxiety neurosis (Sahasi et al., 1991) and psychoneurosis .
Diagnoses were based on DSM-III or DSM-IV-TR in one RCT each. In two studies, the authors did not state how the patients were diagnosed; and one study defined snake phobia as a value on a questionnaire beyond a predefined cut-off. Three RCTs included participants with unspecific (Davis et al., 2015; de Manincor et al., 2016) or specific (examination-related) (Broota & Sanghvi, 1994) anxiety but without a formal diagnosis of an anxiety disorder. A total of 319 participants were included in the eight RCTs; sample size ranged from 12 to 78 (median = 41). Participants' mean age ranged from 30.0 to 38.5 years (median = 36.3 years). Between 26.8 and 100.0% (median = 73.7%) of participants in each study were female; between 0.0 and 78.0%
(median = 78.0%) of participants in each study were Caucasian (where reported).
One RCT used meditation only (Norton & Johnson, 1983) ; the other RCTs used multicomponent yoga interventions, including breathing techniques and/or meditation in addition to physical postures. The intervention in one study was conducted in individual consultations (de Manincor et al., 2016) ; the remaining studies used group classes or did not report whether the intervention was conducted in group classes or individually. Yoga was compared to no specific treatment in three RCTs (Davis et al., 2015; de Manincor et al., 2016; Parthasarathy et al., 2014) and to active comparators, mainly relaxation, in five RCTs (Broota & Sanghvi, 1994; Gupta & Mamidi, 2013; Norton & Johnson, 1983; Sahasi et al., 1991; .
All RCTs assessed anxiety severity. Three also assessed remission rates (de Manincor et al., 2016; Gupta & Mamidi, 2013; Sahasi et al., 1991) , two assessed depression severity (Davis et al., 2015; de Manincor et al., 2016) , and one assessed quality of life (de Manincor et al., 2016) . Only three RCTs reported safety-related data (Davis et al., 2015; de Manincor et al., 2016; Gupta & Mamidi, 2013) .
Risk of bias in individual studies
Risk of selection bias was unclear for most RCTs, only two studies reported adequate random sequence generation (Davis et al., 2015; de Manincor et al., 2016) , and only one reported adequate allocation con- 
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.1 Primary outcomes
Meta-analyses revealed evidence for small short-term effects of yoga on anxiety compared to no treatment (SMD = −0.43; 95% CI = −0.74 to −0.11; P = .008; Figure 3) ; and large effects compared to active comparators (SMD = −0.86; 95% CI = −1.56 to −0.15; P = .02; Figure 3 ).
The single study that compared remission rates between yoga and no treatment found no group differences (de Manincor et al., 2016) . Likewise, no group differences in remission rates between yoga and active comparators were found in the meta-analysis (two RCTs; OR = 1.89; 95% CI = 0.15-24.20; P = .62; I 2 = 0%).
Secondary outcomes
Evidence for small short-term effects of yoga compared to no treat- RCTs reported safety-related data. Two RCTs reported that no adverse events and/or adverse effects (de Manincor et al., 2016; Gupta & Mamidi, 2013) occurred. An RCT on pregnant women with elevated levels of anxiety reported that rates of pregnancy-related adverse events were equal to or lower than the national prevalence rate for such events without specifying rates (Davis et al., 2015) .
Subgroup analyses and sensitivity analyses
Results were comparable to the overall sample when only individuals with elevated levels of anxiety but without a formal diagnosis of an anxiety disorder were included. The same was true for patients that were described to have an anxiety disorder but where the authors did not state how this disorder was diagnosed, and for patients that were diagnosed by questionnaires rather than using adequate diagnostic criteria. No effects were found in studies on patients with anxiety disorders diagnosed according to DSM-III or DSM-IV TR (Table 2) . Results did not change substantially when only RCTs with multicomponent yoga interventions were included in the meta-analysis (Table 2) . No subgroup analyses for posture-based or breathing/meditation-based yoga interventions could be performed because insufficient studies using these interventions were available for each analysis. Regarding country of origin, RCTs conducted in India revealed large positive effects of yoga compared to active comparators on anxiety, whereas RCTs from Western countries found small positive effects of yoga compared to no treatment on anxiety and depression (Table 2) . Studies including both male and female participants found small effects on anxiety and depression for yoga compared to no treatment. Small effects on anxiety were also found in studies including only female participants when comparing yoga to no treatment (Table 2) . No studies including only male participants were included.
The effects of yoga compared to no treatment on anxiety and depression did not change substantially when only RCTs with low risk of selection, detection, or attrition bias were assessed.
DISCUSSION
Summary of results
This systematic review and meta-analysis found that yoga might be beneficial in the short-term for improving intensity of anxiety when compared to untreated controls or active comparators. However, no effects were found when only patients with DSM-diagnosed anxiety disorder were included in the analyses. Overall, the application of yoga was not associated with increased injuries or increased anxiety symptoms, with the caveat that only three RCTs reported safety-related data.
Comparison to prior reviews
Only few systematic reviews have examined the evidence on yoga for insufficient. Yoga appears to be beneficial over no-treatment controls based on the intensity of anxiety, but there are several limitations to this review including the variety of diagnoses included, the heterogeneity of interventions, and the potential bias in the included trials.
As such, no effect in yoga compared to untreated control groups or those treated with other interventions was found in the present review when only studies that applied DSM anxiety disorder diagnosis were included. Thus, the conclusion of this review can still only be consid- b Remission rates were analyzed using odds ratios (95% confidence intervals).
findings that have found associations between anxiety and sympathetic activation, vagal deactivation, an increase in breathing frequency, and a decrease in the depth of breathing (Kreibig, 2010) . It is furthermore supported by studies showing high prevalence of anxiety and depression in patients with breathing disorders (Kunik et al., 2005) . Indeed, breathing retraining has been an essential part of many cognitive behavior therapy approaches for panic disorders (HazlettStevens & Craske, 2009; Schmidt et al., 2000) . Those findings are supplemented by qualitative studies and case reports reporting increased self-efficacy and coping abilities after yoga classes Evans et al., 2011; Williams-Orlando, 2013 ).
Limitations
This systematic review has several limitations. First, the paucity of trials in general, and the paucity of trials for specific anxiety disorders in particular, rendered in depth meta-analyses impossible. Where there was more than one trial for one condition, trials were still heterogeneous regarding sample or intervention characteristics. Second, many of the included trials did not use standardized formal diagnostic criteria, such as the DSM. While diagnostic criteria change over time, the use of such criteria may have more accurately described the participant populations involved in the trials. Third, very few trials included in this review had a low risk of bias regarding random sequence generation, allocation concealment, or blinding. While the latter may be implausible due to the nature of yoga interventions, there are possibilities for reducing the potential risk of bias; for example, by selecting adequate control groups, and examining patients' expectations prior to the trial.
Authors of prospective research would further improve the reporting of yoga trials by adhering to standard reporting guidelines (e.g. CON-SORT). Last, the large effects of yoga compared to active comparators were mainly driven by one of the three included studies while the other two studies had more moderate effects.
Conclusions
The findings of this meta-analysis indicate that yoga might be an effective and safe intervention for individuals with elevated levels of anxiety. While this systematic review found there was no conclusive evidence for the effective use of yoga in anxiety disorders, yoga may, however, be considered a safe (Cramer et al., 2015; Reddy & Vijay, 2016) , ancillary intervention for patients unwilling to commit to other forms of exercise. More high-quality studies are needed and are warranted given these preliminary findings and plausible mechanisms of action.
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